Nikolai G. Rainov, MD DSc FRCSEd
Nikolai G. Rainov, MD DSc FRCSEd
Board-certified Neurosurgeon, Professor of Neurosurgery
Verified email at
Cited by
Cited by
Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas
KS Aboody, A Brown, NG Rainov, KA Bower, S Liu, W Yang, JE Small, ...
Proceedings of the National Academy of Sciences 97 (23), 12846-12851, 2000
NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality
R Stupp, ET Wong, AA Kanner, D Steinberg, H Engelhard, V Heidecke, ...
European journal of cancer 48 (14), 2192-2202, 2012
Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin
AB Brown, W Yang, NO Schmidt, R Carroll, KK Leishear, NG Rainov, ...
Human gene therapy 14 (18), 1777-1785, 2003
Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma
F Weber, A Asher, R Bucholz, M Berger, M Prados, S Chang, J Bruce, ...
Journal of neuro-oncology 64, 125-137, 2003
Ultrasound enhancement of liposome-mediated cell transfection is caused by cavitation effects
S Koch, P Pohl, U Cobet, NG Rainov
Ultrasound in medicine & biology 26 (5), 897-903, 2000
Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy
CM Kramm, M Chase, U Herrlinger, A Jacobs, PA Pechan, NG Rainov, ...
Human gene therapy 8 (17), 2057-2068, 1997
Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 …
H Ren, T Boulikas, A Söling, PC Warnke, NG Rainov
Journal of neuro-oncology 64, 147-154, 2003
Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas
U Herrlinger, C Woiciechowski, M Sena-Esteves, KS Aboody, AH Jacobs, ...
Molecular Therapy 1 (4), 347-357, 2000
Alginate encapsulation of genetically engineered mammalian cells: comparison of production devices, methods and microcapsule characteristics
S Koch, C Schwinger, J Kressler, CH Heinzen, NG Rainov
Journal of microencapsulation 20 (3), 303-316, 2003
First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience
HC Bock, MJA Puchner, F Lohmann, M Schütze, S Koll, R Ketter, ...
Neurosurgical review 33, 441-449, 2010
Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/5-fluorocytosine suicide gene therapy-induced cell death in glioma cells
U Fischer, S Steffens, S Frank, NG Rainov, K Schulze-Osthoff, CM Kramm
Oncogene 24 (7), 1231-1243, 2005
Long-term intrathecal infusion of drug combinations for chronic back and leg pain
NG Rainov, V Heidecke, W Burkert
Journal of pain and symptom management 22 (4), 862-871, 2001
Clinical trials with retrovirus mediated gene therapy–what have we learned?
NG Rainov, H Ren
Journal of neuro-oncology 65, 227-236, 2003
Gene therapy for brain tumors
CM Kramm, M Sena‐Esteves, FH Barnett, NG Rainov, DE Schuback, ...
Brain Pathology 5 (4), 345-381, 1995
Prognostic factors in malignant glioma: influence of the overexpression of oncogene and tumor-suppressor gene products on survival
NG Rainov, KU Dobberstein, H Bahn, HJ Holzhausen, C Lautenschläger, ...
Journal of neuro-oncology 35, 13-28, 1997
Anterior cervical fusion with the Orion locking plate system
V Heidecke, NG Rainov, W Burkert
Spine 23 (16), 1796-1802, 1998
Increased expression of ABCB6 enhances protoporphyrin IX accumulation and photodynamic effect in human glioma
SG Zhao, XF Chen, LG Wang, G Yang, DY Han, L Teng, MC Yang, ...
Annals of surgical oncology 20, 4379-4388, 2013
Intervertebral disc replacement for cervical degenerative disease–clinical results and functional outcome at two years in patients implanted with the Bryan® cervical disc …
V Heidecke, W Burkert, M Brucke, NG Rainov
Acta neurochirurgica 150, 453-459, 2008
Liposome-mediated transfer of the bcl-2 gene results in neuroprotection after in vivo transient focal cerebral ischemia in an animal model
YJ Cao, T Shibata, NG Rainov
Gene therapy 9 (6), 415-419, 2002
New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol
NG Rainov, KU Dobberstein, M Sena-Esteves, U Herrlinger, CM Kramm, ...
Human gene therapy 9 (9), 1261-1273, 1998
The system can't perform the operation now. Try again later.
Articles 1–20